Peer-reviewedCC BYEuropean heart journal open
Circulating anti-Ro/Sjögren’s syndrome-related antigen A antibodies and risk of heart rate-corrected QT interval prolongation: a meta-analysis
Related
- A Conceptual Translational Bench-to-Bedside Cardiac Safety Framework for Predicting Drug-Induced QT Interval Prolongation from Molecular Structure to Clinical Data
- NO EVIDENCE OF QTC INTERVAL PROLONGATION WITH THE MENIN INHIBITOR BLEXIMENIB WHEN GIVEN AS MONOTHERAPY OR IN COMBINATION WITH ACUTE MYELOID LEUKEMIA AML-DIRECTED THERAPIES FOR KMT2A OR NPM1 ALTERED AML
- Antiemetic-associated QT prolongation: a clinical review and risk-stratified prescribing framework for long QT syndrome
- Circulating Nephrin Antibodies and Post-Transplant Recurrence of Diffuse Podocytopathies: A Systematic Review
- Circulating Zonulin in Irritable Bowel Syndrome: A Systematic Review of Conflicting Evidence and the Critical Impact of Assay Specificity
BibTeX
@article{anon2026circulating,
title = {{Circulating anti-Ro/Sjögren’s syndrome-related antigen A antibodies and risk of heart rate-corrected QT interval prolongation: a meta-analysis}},
journal = {European heart journal open},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13663800},
note = {CC BY},
}
RIS
TY - JOUR
TI - Circulating anti-Ro/Sjögren’s syndrome-related antigen A antibodies and risk of heart rate-corrected QT interval prolongation: a meta-analysis
PY - 2026
DA - 2026/08/14
JO - European heart journal open
UR - https://europepmc.org/article/PMC/PMC13663800
SN - 2752-4191
ER -